NasdaqGM:CRSPBiotechs
CRISPR Therapeutics (CRSP) Surges 71% Last Quarter With Inclusion In Russell Indices
CRISPR Therapeutics (CRSP) has recently been included in numerous Russell indices, highlighting its increasing market recognition. This, coupled with promising advancements in their cardiovascular disease programs, may have significantly impacted the company's 71% price move last quarter. While the broader market also experienced gains, with the S&P 500 closing at record highs, CRSP's substantial rise stands out, possibly buoyed by these pivotal company-specific events, in addition to general...